Race
Visit number vs Insulin
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 49 | 17.8 | ± 10.3 | 14.5 | 4.8 | 46.0 | - | 49 |
9-Month Followup | 43 | 15.5 | ± 12.8 | 11.1 | 3.5 | 54.9 | - | 43 |
18-Month Followup | 39 | 17.5 | ± 18.0 | 10.9 | 3.1 | 89.1 | 1 | 40 |
Randomized treatment arm vs Insulin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 17.8 | ± 10.3 | 14.5 | 4.8 | 46.0 | - | 49 |
Laparoscopic Gastric Banding (LGB) | 28 | 17.1 | ± 10.1 | 14.9 | 5.8 | 46.0 | - | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 18.8 | ± 10.7 | 14.5 | 4.8 | 45.2 | - | 21 |
Randomized treatment arm vs Insulin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 15.5 | ± 12.8 | 11.1 | 3.5 | 54.9 | - | 43 |
Laparoscopic Gastric Banding (LGB) | 25 | 12.6 | ± 10.8 | 8.5 | 4.4 | 54.9 | - | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 19.6 | ± 14.4 | 17.6 | 3.5 | 48.5 | - | 18 |
Randomized treatment arm vs Insulin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 39 | 17.5 | ± 18.0 | 10.9 | 3.1 | 89.1 | 1 | 40 |
Laparoscopic Gastric Banding (LGB) | 23 | 12.5 | ± 9.3 | 9.1 | 3.1 | 39.3 | 1 | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 24.7 | ± 24.5 | 16.9 | 4.0 | 89.1 | - | 16 |
Age of the participant vs Insulin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 17.8 | ± 10.3 | 14.5 | 4.8 | 46.0 | - | 49 |
27.0 to 45.0 years | 13 | 19.2 | ± 9.7 | 17.2 | 7.2 | 38.3 | - | 13 |
46.0 to 50.0 years | 12 | 17.8 | ± 11.3 | 14.2 | 6.0 | 46.0 | - | 12 |
51.0 to 56.0 years | 12 | 19.7 | ± 12.4 | 17.7 | 4.8 | 45.2 | - | 12 |
57.0 to 65.0 years | 12 | 14.4 | ± 7.8 | 12.8 | 5.8 | 28.6 | - | 12 |
Age of the participant vs Insulin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 15.5 | ± 12.8 | 11.1 | 3.5 | 54.9 | - | 43 |
28.0 to 47.0 years | 11 | 18.3 | ± 11.1 | 16.0 | 6.4 | 44.5 | - | 11 |
47.0 to 52.0 years | 11 | 14.9 | ± 15.0 | 10.1 | 3.5 | 54.9 | - | 11 |
52.0 to 58.0 years | 11 | 18.9 | ± 15.9 | 12.1 | 3.9 | 48.5 | - | 11 |
58.0 to 65.0 years | 10 | 9.5 | ± 5.5 | 6.9 | 4.4 | 19.5 | - | 10 |
Age of the participant vs Insulin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 39 | 17.5 | ± 18.0 | 10.9 | 3.1 | 89.1 | 1 | 40 |
29.0 to 46.0 years | 10 | 21.4 | ± 10.9 | 20.6 | 5.3 | 39.3 | - | 10 |
47.0 to 52.0 years | 10 | 11.7 | ± 8.2 | 8.5 | 4.0 | 26.5 | - | 10 |
53.0 to 58.0 years | 10 | 27.6 | ± 30.3 | 13.9 | 6.9 | 89.1 | - | 10 |
58.0 to 65.0 years | 9 | 8.5 | ± 4.4 | 8.6 | 3.1 | 16.1 | 1 | 10 |
Gender of the participant vs Insulin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 17.8 | ± 10.3 | 14.5 | 4.8 | 46.0 | - | 49 |
Male | 28 | 18.1 | ± 10.6 | 15.7 | 6.0 | 46.0 | - | 28 |
Female | 21 | 17.4 | ± 10.2 | 14.5 | 4.8 | 45.2 | - | 21 |
Gender of the participant vs Insulin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 15.5 | ± 12.8 | 11.1 | 3.5 | 54.9 | - | 43 |
Male | 25 | 17.4 | ± 13.8 | 12.1 | 3.5 | 54.9 | - | 25 |
Female | 18 | 13.0 | ± 11.0 | 10.3 | 3.9 | 48.5 | - | 18 |
Gender of the participant vs Insulin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 39 | 17.5 | ± 18.0 | 10.9 | 3.1 | 89.1 | 1 | 40 |
Male | 24 | 17.8 | ± 15.8 | 12.8 | 4.0 | 76.4 | 1 | 25 |
Female | 15 | 17.2 | ± 21.7 | 9.0 | 3.1 | 89.1 | - | 15 |
Race of the participant vs Insulin
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 46 | 17.7 | ± 10.3 | 14.9 | 4.8 | 46.0 | - | 46 |
white | 35 | 16.9 | ± 8.6 | 14.5 | 4.8 | 38.3 | - | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 21.7 | ± 15.8 | 19.0 | 5.8 | 46.0 | - | 9 |
asian | 2 | 14.5 | ± 3.8 | 14.5 | 11.8 | 17.2 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Insulin
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 15.8 | ± 13.2 | 11.1 | 3.5 | 54.9 | - | 40 |
white | 31 | 14.3 | ± 11.0 | 10.5 | 3.9 | 45.1 | - | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 8 | 22.9 | ± 19.2 | 18.3 | 3.5 | 54.9 | - | 8 |
asian | 1 | 6.9 | - | 6.9 | 6.9 | 6.9 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Insulin
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 36 | 17.9 | ± 18.7 | 10.3 | 3.1 | 89.1 | 1 | 37 |
white | 29 | 16.3 | ± 15.2 | 9.8 | 3.1 | 76.4 | - | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 6 | 27.3 | ± 31.7 | 20.0 | 4.0 | 89.1 | 1 | 7 |
asian | 1 | 9.1 | - | 9.1 | 9.1 | 9.1 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |